‌

US Patent 12071443 Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Xiao Ding0

Feng Ren0

Jianyu Xu0

Liena Qin0

Date of Patent

August 27, 2024

0

Patent Application Number

183393620

Date Filed

June 22, 2023

0

Patent Citations

US Patent 8629131 Enhanced erythropoiesis and iron metabolism

0

US Patent 9920011 Enhanced erythropoiesis and iron metabolism

0

US Patent 8962530 Inflammatory bowel disease therapies

0

US Patent 9994566 Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation method thereof and pharmaceutical use thereof

0

US Patent 8604012 Enhanced erythropoiesis and iron metabolism

0

US Patent 8609646 Enhanced erythropoiesis and iron metabolism

0

Patent Primary Examiner

Niloofar Rahmani

0

CPC Code

0

Patent abstract

Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12071443 Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool